a public good project by the
Synthesis
Company
of California

© 2026

Katsuaki Hoshino | doi.page

0 works0 citations0 h-index

Katsuaki Hoshino

Shinshu University(JP)University of Queensland(AU)Kagawa University(JP)RIKEN Center for Integrative Medical Sciences(JP)Ōtani University(JP)

Publications by Year

Research Areas

Immune Response and Inflammation, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, NF-κB Signaling Pathways, T-cell and B-cell Immunology

Most-Cited Works

→ A Toll-like receptor recognizes bacterial DNA(2000)6,388 cited
→ Cutting Edge: Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as the Lps Gene Product(1999)3,357 cited
→ Differential Roles of TLR2 and TLR4 in Recognition of Gram-Negative and Gram-Positive Bacterial Cell Wall Components(1999)3,351 cited
→ Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway(2003)3,180 cited
→ Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway(2002)2,484 cited
→ Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins(2002)1,312 cited

→ Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling(2002)

1,222 cited

→ Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes(2001)1,088 cited

→ Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection(2000)1,046 cited

→ TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway(2003)1,042 cited